Filtered By:
Infectious Disease: Coronavirus
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 2387 results found since Jan 2013.
Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease Aimmune Says Patients Begin Treatment With Peanut Allergy Drug as COVID-19 Lockdowns Ease
Aimmune Therapuetics said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to patients as allergy specialists reopen, the drugmaker ' s executives told Reuters on Thursday.Reuters Health Information
Source: Medscape Allergy Headlines - July 6, 2020 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news
Drug allergy labeling and delabeling in the coronavirus disease 2019 era: What is important and what do we need to know.
PMID: 32448437 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - May 27, 2020 Category: Allergy & Immunology Authors: Castells MC Tags: Ann Allergy Asthma Immunol Source Type: research
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019.
PMID: 32859351 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - August 30, 2020 Category: Allergy & Immunology Authors: Ciprandi G, Licari A, Filippelli G, Tosca MA, Marseglia GL Tags: Ann Allergy Asthma Immunol Source Type: research
Paediatric allergy practice in the era of coronavirus disease 2019
Purpose of review
To summarize the impact of the COVID-19 pandemic on the practice of paediatric allergy.
Recent findings
Given significant overlap in symptoms, care must be taken to differentiate routine allergic conditions from COVID-19 infection but it appears that most allergic diseases are not risk factors for a severe COVID-19 course. The full impact of restricted allergy/immunology ambulatory services will take months to years to fully understand. One benefit of having to adapt practice style is greater awareness and acceptance of shared decision-making and recognition of preference-sensitive care options...
Source: Current Opinion in Allergy and Clinical Immunology - March 3, 2021 Category: Allergy & Immunology Tags: PEDIATRIC ASTHMA AND DEVELOPMENT OF ATOPY: Edited by Andy Liu and Pasquale Comberiati Source Type: research
The Use and Teaching of Telemedicine in Allergy/Immunology Training Programs
AbstractPurpose of ReviewThe use of telemedicine has greatly increased since the onset of the coronavirus disease 2019 (COVID-19) pandemic. This review discusses the types of telemedicine, current telehealth curricula in medical education, and benefits and disadvantages of incorporation of telemedicine into Allergy/Immunology training programs.Recent FindingsThe majority of Allergists/Immunologists use telemedicine in their clinical practice with leaders in graduate medical education recommending inclusion of telemedicine in training. Fellows-in-training reported that use of telemedicine in Allergy/Immunology training duri...
Source: Current Allergy and Asthma Reports - July 7, 2023 Category: Allergy & Immunology Source Type: research
COVID-19 mRNA vaccine allergy
Purpose of review
A known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine is the only contraindication to coronavirus disease 2019 (COVID-19) mRNA vaccination. It is important for pediatricians to understand the likelihood of an allergic reaction to COVID-19 mRNA vaccines, including its excipients.
Recent findings
Episodes concerning for anaphylaxis were immediately reported following early administration of COVID-19 mRNA vaccines to adults. Although allergic type symptoms were reported equally in recipients of placebos and test vaccines in phase 3 clinical trials, post-...
Source: Current Opinion in Pediatrics - November 10, 2021 Category: Pediatrics Tags: ALLERGY, IMMUNOLOGY AND RELATED DISORDERS: Edited by Jordan S. Orange Source Type: research
Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy
CONCLUSION: COVID-19 had a considerable psychological impact on patients with asthma. Limited data have been published on the mental health impacts of COVID-19 on patients with allergic rhinitis and food allergy. As COVID-19 research continues to evolve and the literature captures later stages of the pandemic, it is important that physicians be aware of the potential coincidence of mental illness and chronic allergic diseases and refer these patients, and their caregivers, to appropriate resources while also continuing to manage their allergic disease(s).PMID:34971763 | PMC:PMC8714612 | DOI:10.1016/j.anai.2021.12.013
Source: Annals of Allergy, Asthma and Immunology - December 31, 2021 Category: Allergy & Immunology Authors: Alyssa G Burrows Anne K Ellis Source Type: research
An academic allergy unit during COVID-19 pandemic in Italy
Recently, Codispoti et al1 delineated the clinical and academic challenges that the coronavirus disease 2019 (COVID-19) pandemic raised at their Division of Allergy and Immunology. They rapidly coordinated a lot of stressful changes in established practices to meet academic and health care needs. Besides congratulating the authors for their promptness, we here share our experience in getting across the COVID-19 pandemic in our Allergy Clinic, at Humanitas Research Hospital in Milan, where the epidemic first started in Italy.
Source: Journal of Allergy and Clinical Immunology - April 17, 2020 Category: Allergy & Immunology Authors: Giacomo Malipiero, Giovanni Paoletti, Francesca Puggioni, Francesca Racca, Sebastian Ferri, Antonino Marsala, Ornella Leoncini, Monica Porli, Gabriella Pieri, Giorgio Walter Canonica, Enrico Heffler Tags: Correspondence Source Type: research
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
ConclusionDuring COVID-19 pandemic, allergists have the responsibility of balancing individual patients ’ needs with public health issues, and innovative tools, such as telemedicine and digital medicine services, can be helpful to reduce the risk of viral spreading while delivering up-to-date personalized care.
Source: Clinical and Translational Allergy - June 17, 2020 Category: Allergy & Immunology Source Type: research
Management of Allergic Patients During the COVID-19 Pandemic in Asia.
We report this consensus to support allergists and clinical immunologists to make optimal decisions under the urgent situation in Asia.
PMID: 32638559 [PubMed]
Source: Allergy, Asthma and Immunology Research - July 10, 2020 Category: Allergy & Immunology Tags: Allergy Asthma Immunol Res Source Type: research
Social well-being among children with vs without food allergy before and during coronavirus disease 2019
Prepandemic studies note high rates of bullying among children with food allergy, specifically because of their condition, often on school grounds such as on the playground or in the classroom.1 In addition, we have recently reported that, among mothers of children with food allergy, 44% reported symptoms indicative of clinical anxiety.2 Whereas anxiety has increased in children and their families, children who experience bullying at school —such as those with food allergy—may have indirectly experienced a reprieve as a result of pandemic-related physical distancing and public health restrictions.
Source: Annals of Allergy, Asthma and Immunology - March 3, 2022 Category: Allergy & Immunology Authors: Kaitlyn A. Merrill, Elissa M. Abrams, Elinor Simons, Jennifer Lisa Penner Protudjer Tags: Letters Source Type: research
The role of viruses in the clinical presentation of chronic rhinosinusitis.
CONCLUSION: Although traditionally difficult, advances in molecular sequencing enhance detection of viruses in the sinonasal tract. In this study, respiratory viruses were more commonly isolated from patients with CRS compared with healthy controls. Moreover, viral infection may play a greater role in symptom exacerbation in CRSsNP than in CRSwNP. These findings warrant further investigation into the role of the viral microbiome in CRS.
PMID: 26637569 [PubMed - in process]
Source: American Journal of Rhinology and Allergy - November 1, 2015 Category: ENT & OMF Authors: Rowan NR, Lee S, Sahu N, Kanaan A, Cox S, Phillips CD, Wang EW Tags: Am J Rhinol Allergy Source Type: research
Coronavirus disease (covid)-19: world health organization definitions and coding to support the allergy community and health professionals
Publication date: Available online 11 May 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Luciana Kase Tanno, Thomas Casale, Pascal Demoly
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 11, 2020 Category: Allergy & Immunology Source Type: research
Rhinologic Procedures in the Era of COVID-19: Health-care Provider Protection Protocol.
CONCLUSION: According to our proposed protocol, we were able to provide care for all patients in clinic, hospital, emergent, intensive, and surgical settings with no transmission of SARS-CoV-2 by symptomatology and post evaluation testing.
PMID: 32408753 [PubMed - as supplied by publisher]
Source: American Journal of Rhinology and Allergy - May 13, 2020 Category: ENT & OMF Authors: Taha MA, Hall CA, Rathbone RF, Corsten LA, Bowie CR, Waguespack PJ, Stanger R, Stevenson MM, Zito BA, Barham HP Tags: Am J Rhinol Allergy Source Type: research
